03384nam a22004815i 4500001001800000003000900018005001700027007001500044008004100059020001800100024003500118050001200153072001600165072002300181072001500204245015200219250001800371264006900389300006600458336002600524337002600550338003600576347002400612505096200636520069301598650002702291650001402318650003002332650001402362650001902376650001402395650001902409650001802428700007902446700008202525700008102607710003402688773002602722776003602748776003602784776003602820856004602856978-3-031-64021-6DE-He21320251030112928.0cr nn 008mamaa240901s2024    sz |    s    |||| 0|eng d  a97830316402167 a10.1007/978-3-031-64021-62doi 4aRS199.5 7aTCB2bicssc 7aSCI0100002bisacsh 7aTCB2thema10aPharmacoproteomicsh[electronic resource] :bRecent Trends and Applications /cedited by Seth K. Amponsah, Kwabena F. M. Opuni, Yashwant V. Pathak.  a1st ed. 2024. 1aCham :bSpringer Nature Switzerland :bImprint: Springer,c2024.  aXVI, 471 p. 100 illus., 50 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aOverview of pharmacoproteomics and its clinical applications -- Pharmacoproteomics and precision medicine -- Pharmacoproteomics and drug target discovery -- Analytical methods in pharmacoproteomics -- Bridging the gap between pharmacoproteomics and pharmacogenomics -- Analysis and interpretation of pharmacoproteomic data -- Pharmacoproteomics and sickle cell management -- Pharmacoproteomics and cancer management -- Pharmacoproteomics and neurological disease management -- Pharmacoproteomics and rheumatoid arthritis management -- Proteomics and management of multiple sclerosis -- Biomarker development against infections using proteomics -- Proteomics and COVID-19: recent trends -- Proteomics in the pharmaceutical industry: prospects and challenges -- Nanomaterials in proteomics -- Big data analytics in pharmacoproteomics -- Recent mass spectrometry technologies in pharmacoproteomics -- High throughput pre-clinical models and pharmacoproteomics.  aThis book gives an overview of pharmacoproteomics and its clinical applications, as well as the latest information on drug mechanisms at the proteome level, the relationship between proteomics and toxicity or resistance, and how proteomics aid in discovery of new drug targets. The book also highlights recent advances in analytical methods, analysis, and interpretation of pharmacoproteomic data. Pharmacoproteomics: Recent Trends and Applications is an ideal book for those working in pharmaceutical industries, as well as scientists, health care professionals, and researchers who work in the field of genomics, pharmacology, pharmacokinetics, toxicology, and pharmaceutical chemistry. 0aDrug delivery systems. 0aProteins. 0aPharmaceutical chemistry. 0aCytology.14aDrug Delivery.24aProteins.24aPharmaceutics.24aCell Biology.1 aAmponsah, Seth K.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt1 aOpuni, Kwabena F. M.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt1 aPathak, Yashwant V.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt2 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303164020908iPrinted edition:z978303164022308iPrinted edition:z978303164023040uhttps://doi.org/10.1007/978-3-031-64021-6